Regencell Bioscience Holdings Limited
RGC
Rangering i aksjer
#3446
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Aksjekurs
$10.10
Markedsverdi
$5.01B
Endring (1 dag)
5.32%
Endring (1 år)
-41.99%
Land
HK
Handel Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
EPS for Regencell Bioscience Holdings Limited (RGC)
EPS per June 2026 TTM: $-0.02
Ifølge de siste økonomiske rapportene og aksjekursen til Regencell Bioscience Holdings Limited er selskapets nåværende EPS (TTM) $-0.02. Ved slutten av 2024 hadde selskapet en EPS på $-0.01, lik EPS-en i 2023 som var $-0.01.
EPS-historikk for Regencell Bioscience Holdings Limited fra 2019 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $-0.02 | 136.00% |
| 2025 | $-0.01 | -17.24% |
| 2024 | $-0.01 | -26.89% |
| 2023 | $-0.01 | -20.67% |
| 2022 | $-0.02 | 435.71% |
| 2021 | 0.00 | 64.71% |
| 2020 | 0.00 | 112.50% |
| 2019 | 0.00 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2,457.20% |
IN
|
